Biotech - Press Releases

Date	Title	Company
29-Oct-2019	Sense Biodetection Raises £12.3m to Progress Instrument-Free Molecular Diagnostics	Sense Biodetection Limited
29-Oct-2019	Polyplus-transfection(R) adds to transfection reagent portfolio for vaccination and cancer research	Polyplus-transfection(R) SA
29-Oct-2019	European CNS specialist Neuraxpharm enters booming CBD market	Neuraxpharm Group
29-Oct-2019	USDA-USMARC Streamlines Research Operations with L7 Informatics NGS LIMS System	L7 Informatics, Inc.
29-Oct-2019	ATCC Releases Cell-Specific Exosomes as Reference Materials for Drug and Diagnostic Development	ATCC
29-Oct-2019	AbbVie Launches Let Me Be Clear to Empower People with Psoriasis to Speak Up and Seek Freedom from Their Disease	AbbVie
29-Oct-2019	Linnaeus Therapeutics Announces First Patient Dosed in Its Phase 1/2 Clinical Trial of LNS8801 in Patients with Advanced Cancer	Linnaeus Therapeutics, Inc.
29-Oct-2019	XBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa	XBiotech
29-Oct-2019	Tillotts partners Menarini to extend Asacol® to the People’s Republic of China	Tillotts Pharma AG
29-Oct-2019	Oracle Health Sciences and Phlexglobal Collaborate to Reduce Operational Bottlenecks in Clinical Research	Phlexglobal
29-Oct-2019	BioMed X Completes Alzheimer’s Disease Research Project	BioMed X Innovation Center
29-Oct-2019	Apex Physics Partners Promotes Jessica Perovic To Vice President Of Finance	Apex Physics Partners
29-Oct-2019	Creative Enzymes Launches Three New Enzyme Products to Meet the Diverse Market Demand	Creative Enzymes
28-Oct-2019	Synthetic Biologics to Report 2019 Third Quarter Operational Highlights and Financial Results on November 4, 2019	Synthetic Biologics, Inc.
28-Oct-2019	Prelude Therapeutics expands in Delaware; Adding biotech jobs in cancer drug discovery research	Delaware Prosperity Partnership
28-Oct-2019	Lonza to Host New Webinar – “Paper to EBR in 9 Months: How a Strong Collaboration Leads to Project Success”	Lonza
28-Oct-2019	ORIC Pharmaceuticals Presents Preclinical Data on Glucocorticoid Receptor Antagonist and CD73 Inhibitor Programs at AACR-NCI-EORTC Annual Conference	ORIC Pharmaceuticals
28-Oct-2019	Heron Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for HTX-011 for Management of Postoperative Pain	Heron Therapeutics, Inc.
28-Oct-2019	VistaGen Therapeutics Expands European Patent Protection for AV-101 for Treatment of Depression and Dyskinesia associated with Levodopa Therapy for Parkinson's Disease	VistaGen Therapeutics
28-Oct-2019	Arena Pharmaceuticals Announces First Subject Dosed in ADVISE Phase 2 Trial Evaluating Etrasimod in Atopic Dermatitis	Arena Pharmaceuticals, Inc.